Lightstone Ventures, Temasek’s ClavystBio co-lead Allay Therapeutics’ US$57.5 million Series D funding
The company’s technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation United ...
The company’s technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation United ...
Nissan Motor, facing a huge loan repayment wall next year, is seeking to raise more than one trillion yen (S$7 ...
Hibor extended its drop as it fell below 1% on Tuesday (May 20) for the first time since 2022Published Tue, ...
New Delhi: Defence Minister Rajnath Singh has asked the International Monetary Fund (IMF) to reconsider its $2.1 billion bailout to ...
Gov. Gavin Newsom proposed slashing funding by 67% for a pioneering deal with Google to support struggling California newsrooms, citing ...
London: The World Health Organization has reduced its management team by half and will have to scale back operations, its ...
US President Donald Trump's administration slashed cancer research funding by 31 per cent in the first three months of 2025 ...
Published Mon, May 12, 2025 · 07:44 AM OpenAI and Microsoft are rewriting terms of their multibillion-dollar partnership in a ...
Published Thu, Apr 24, 2025 · 01:21 PM Flag-carrier Vietnam Airlines said on Thursday (Apr 24) it had signed a ...
The cost to borrow the offshore renminbi in Hong Kong dropped to the lowest since data became available in 2013, ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.